Anthera Pharmaceuticals Inc

Current insiders at Anthera Pharmaceuticals Inc

• Azan Alain10% owner
• Bianchi AnnetteDirector
• Buatois Eric10% owner
• Dickinson KlaraChief Regulatory Officer
• DZIURZYNSKI BOGDANDirector
• ENGLE STEVEN BDirector
• Fritsch UrsulaVP, Glob. Reg. & Compliance
• Furse BrentDirector
• HEALY JAMESDirector
• HEALY JAMES10% owner
• HENNEY CHRISTOPHER SDirector
• Hislop ColinChief Medical Officer
• ISALY SAMUEL DDirector
• ISALY SAMUEL D10% owner
• KILFOIL GEORGINASVP,Product Dev.& Project Mgmt
• Lau StephenVP, Corp. & Business Dev.
• Leheny A. RachelDirector
• LIU MAYPrincipal Accounting Officer
• LOWE CHRISTOPHER P.CFO and Chief Business Officer
• McManigle Mark DrewDirector
• McManigle Mark DrewChief Liquidating Officer
• Mueller BrianDirector
• ODINK DEBRADirector
• ODINK DEBRAChief Technology Officer
• Olson Charles VChief Technology Officer
• ORBIMED ADVISORS LLCDirector
• ORBIMED ADVISORS LLC10% owner
• OrbiMed Capital GP IV LLCDirector
• OrbiMed Capital GP IV LLC10% owner
• Pennington JamesInterim Chief Medical Officer
• PENNINGTON JAMES EChief Medical Officer & Ex. VP
• POWELL MICHAEL10% owner
• Sager PhilipDirector
• SALZMAN ALAN E10% owner
• Santel Donald JDirector
• SHANAHAN WILLIAM R JRDirector
• SHANAHAN WILLIAM R JRChief Medical Officer
• Sofinnova Management VI, L.L.C.10% owner
• Sofinnova Venture Affiliates VI LP10% owner
• Sofinnova Venture Partners VI GmbH & Co. KG10% owner
• SOFINNOVA VENTURE PARTNERS VI L P10% owner
• SPIEGELMAN DANIEL KDirector
• Thompson David E.Director
• THOMPSON JOHN CRAIGDirector
• THOMPSON JOHN CRAIGPresident & CEO
• Thompson Peter ADirector
• Trias JoaquimSr. VP, Preclinical Developmen
• TRUEX PAUL FDirector
• TRUEX PAUL FExecutive Chaiman
• VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% owner
• VANTAGEPOINT VENTURE PARTNERS IV LP10% owner
• VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP10% owner
• VANTAGEPOINT VENTURE PARTNERS IV Q LP10% owner
• Zenyaku Kogyo Co., Ltd.10% owner
• ZWEIFACH SANFORD SDirector

Insider transaction history at Anthera Pharmaceuticals Inc